Updated Recommendations From the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021
Supporting Files
Public Domain
-
-
-
Series:
File Language:
English
Details
-
Description:What is already known about this topic? On April 13, 2021, CDC and the Food and Drug Administration (FDA) recommended pausing use of the Janssen COVID-19 vaccine after reports of thrombosis with thrombocytopenia syndrome (TTS) among vaccine recipients.
What is added by this report? On April 23, the Advisory Committee on Immunization Practices concluded that the benefits of resuming Janssen COVID-19 vaccination among persons aged ≥18 years outweighed the risks and reaffirmed its interim recommendation under FDA's Emergency Use Authorization, which includes a new warning for rare clotting events among women aged 18-49 years.
What are the implications for public health practice? Resuming use of the Janssen COVID-19 vaccine will ensure flexibility, choice, and improved access. Education about TTS risk with Janssen COVID-19 vaccine is critical.
Suggested citation for this article: MacNeil JR, Su JR, Broder KR, et al. Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021. MMWR Morb Mortal Wkly Rep. ePub: 27 April 2021.
mm7017e4.htm?s_cid=mm7017e4_w
mm7017e4-H.pdf -
Subjects:
-
ISSN:0149-2195 (print) ; 1545-861X (digital)
-
Document Type:
-
Corporate as Subject:
-
Place as Subject:
-
Location:
-
Pages in Document:6 pdf pages
-
Volume:70
-
Download URL:
-
File Type:
-
Collection(s):
-
Main Document Checksum:urn:sha-512:07700b022752a4580959d6bd1928e14978da47e98bddd3db57dbe0098bc29d6febc2e3f537c6de791d5b8431e832eed3b79bf74dd0f6cdeb504d85b719132e26
Supporting Files
File Language:
English
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings, journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like